|
|
| Quarterly Results |
|
| Biocon Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Kiran Mazumdar Shaw | | Home : Indian Private | Book Value: 90.3831418 | | BSE Code : 532523 | Market Cap: 36858.42 | | NSE Code : BIOCON | P / E : 0 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 562.80 | 518.70 | 513.20 | 506.70 | | Other Income | 48.50 | 69.60 | 55.70 | 1917.60 | | Total Income | 611.30 | 588.30 | 568.90 | 2424.30 | | Total Expenditure | 491.50 | 456.70 | 441.20 | 550.70 | | Operating Profit | 119.80 | 131.60 | 127.70 | 1873.60 | | Interest | 56.00 | 55.00 | 48.30 | 48.10 | | Gross Profit | 63.80 | 76.60 | 79.40 | 1825.50 | | Depreciation | 30.90 | 30.60 | 29.80 | 29.40 | | Tax | 12.30 | 8.20 | 3.90 | -12.90 | | Deferred Tax | -3.40 | 3.10 | -0.90 | -1.80 | | Reported Profit After Tax | 24.00 | 34.70 | 46.60 | 1810.80 |
|
|
|
|
|